Summary of Study ST001082
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000724. The data can be accessed directly via it's Project DOI: 10.21228/M83D5V This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001082 |
Study Title | Combined NMR and MS Analysis of PC patien serum (part-II) |
Study Summary | Serum of two groups of patients were analyzed using MS and NMR to find predictive markers of recurrence. Factor Sample Type in study design section refers to samples with Recurrence (R)/ No Recurrence (NR)/ Blank (B) / Pooled (P). |
Institute | Georgia Institute of Technology |
Department | Department of Chemistry |
Laboratory | Fernandez |
Last Name | Fernandez |
First Name | Facundo |
Address | 901 Atlantic Dr NE, Atlanta, GA, 30332, USA |
fernandez@gatech.edu | |
Phone | 404-385-4432 |
Submit Date | 2018-10-19 |
Num Groups | 2 |
Total Subjects | 80 |
Num Males | 80 |
Analysis Type Detail | LC-MS |
Release Date | 2020-01-13 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000724 |
Project DOI: | doi: 10.21228/M83D5V |
Project Title: | Preoperative Metabolic Signatures of Prostate Cancer Recurrence Following Radical Prostatectomy |
Project Summary: | Prostate cancer patient serum was analyzed using HILIC and RP LC/MS and NMR. |
Institute: | Georgia Institute of Technology |
Last Name: | Fernandez |
First Name: | Facundo |
Address: | 901 Atlantic Dr NE, Atlanta, GA, 30332, USA |
Email: | fernandez@gatech.edu |
Phone: | 404-385-4432 |
Subject:
Subject ID: | SU001126 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 44-70 |
Gender: | Male |
Human Inclusion Criteria: | Prostatectomy patients |
Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample Type |
---|---|---|
SA073015 | B_f | Blank |
SA073016 | sb_f | Blank |
SA073017 | MP1 | Blank |
SA073018 | MP2 | Blank |
SA073019 | MP5 | Blank |
SA073020 | S19_2 | No Recurrence |
SA073021 | S18_3 | No Recurrence |
SA073022 | S19_3 | No Recurrence |
SA073023 | S19_1 | No Recurrence |
SA073024 | S20A_3 | No Recurrence |
SA073025 | S18_2 | No Recurrence |
SA073026 | S20A_2 | No Recurrence |
SA073027 | S20A_1 | No Recurrence |
SA073028 | S17_1 | No Recurrence |
SA073029 | S16_2 | No Recurrence |
SA073030 | S16_1 | No Recurrence |
SA073031 | S16_3 | No Recurrence |
SA073032 | S20B_1 | No Recurrence |
SA073033 | S17_3 | No Recurrence |
SA073034 | S17_2 | No Recurrence |
SA073035 | S18_1 | No Recurrence |
SA073036 | S21_2 | No Recurrence |
SA073037 | S23_3 | No Recurrence |
SA073038 | S23_2 | No Recurrence |
SA073039 | S24_1 | No Recurrence |
SA073040 | S24_2 | No Recurrence |
SA073041 | S26_1 | No Recurrence |
SA073042 | S24_3 | No Recurrence |
SA073043 | S23_1 | No Recurrence |
SA073044 | S22_3 | No Recurrence |
SA073045 | S21_1 | No Recurrence |
SA073046 | S20B_3 | No Recurrence |
SA073047 | S14_3 | No Recurrence |
SA073048 | S21_3 | No Recurrence |
SA073049 | S22_2 | No Recurrence |
SA073050 | S22_1 | No Recurrence |
SA073051 | S20B_2 | No Recurrence |
SA073052 | S13B_2 | No Recurrence |
SA073053 | S6_2 | No Recurrence |
SA073054 | S6_1 | No Recurrence |
SA073055 | S6_3 | No Recurrence |
SA073056 | S8_1 | No Recurrence |
SA073057 | S8_3 | No Recurrence |
SA073058 | S8_2 | No Recurrence |
SA073059 | S5_3 | No Recurrence |
SA073060 | S5_2 | No Recurrence |
SA073061 | S3_3 | No Recurrence |
SA073062 | S3_2 | No Recurrence |
SA073063 | S4_1 | No Recurrence |
SA073064 | S4_2 | No Recurrence |
SA073065 | S5_1 | No Recurrence |
SA073066 | S4_3 | No Recurrence |
SA073067 | S9_1 | No Recurrence |
SA073068 | S9_2 | No Recurrence |
SA073069 | S13A_3 | No Recurrence |
SA073070 | S13A_2 | No Recurrence |
SA073071 | S13B_1 | No Recurrence |
SA073072 | S26_2 | No Recurrence |
SA073073 | S14_1 | No Recurrence |
SA073074 | S13B_3 | No Recurrence |
SA073075 | S13A_1 | No Recurrence |
SA073076 | S12_3 | No Recurrence |
SA073077 | S11_1 | No Recurrence |
SA073078 | S9_3 | No Recurrence |
SA073079 | S11_2 | No Recurrence |
SA073080 | S11_3 | No Recurrence |
SA073081 | S12_2 | No Recurrence |
SA073082 | S12_1 | No Recurrence |
SA073083 | S14_2 | No Recurrence |
SA073084 | S27_2 | No Recurrence |
SA073085 | S47_1 | No Recurrence |
SA073086 | S46_3 | No Recurrence |
SA073087 | S46_2 | No Recurrence |
SA073088 | S47_2 | No Recurrence |
SA073089 | S47_3 | No Recurrence |
SA073090 | S66A_2 | No Recurrence |
SA073091 | S66A_1 | No Recurrence |
SA073092 | S46_1 | No Recurrence |
SA073093 | S44_3 | No Recurrence |
SA073094 | S43_1 | No Recurrence |
SA073095 | S42_3 | No Recurrence |
SA073096 | S43_2 | No Recurrence |
SA073097 | S43_3 | No Recurrence |
SA073098 | S44_2 | No Recurrence |
SA073099 | S44_1 | No Recurrence |
SA073100 | S66A_3 | No Recurrence |
SA073101 | S66B_1 | No Recurrence |
SA073102 | S72_2 | No Recurrence |
SA073103 | S72_1 | No Recurrence |
SA073104 | S72_3 | No Recurrence |
SA073105 | S77_1 | No Recurrence |
SA073106 | S77_3 | No Recurrence |
SA073107 | S77_2 | No Recurrence |
SA073108 | S70_3 | No Recurrence |
SA073109 | S70_2 | No Recurrence |
SA073110 | S66B_3 | No Recurrence |
SA073111 | S66B_2 | No Recurrence |
SA073112 | S67_1 | No Recurrence |
SA073113 | S67_2 | No Recurrence |
SA073114 | S70_1 | No Recurrence |
Collection:
Collection ID: | CO001120 |
Collection Summary: | After Emory Institutional Review Board (IRB) approval, patients were consented and blood collected in SST Serum Separation Tubes: Hemogard (Fisher Scientific). Serum was separated by centrifugation at 1300 rcf for 20 min at 4 °C. Serum aliquots were stored long term in liquid nitrogen until removed for analysis. |
Sample Type: | Blood (serum) |
Collection Location: | Emory University |
Collection Frequency: | Pre-operative |
Storage Conditions: | Described in summary |
Treatment:
Treatment ID: | TR001140 |
Treatment Summary: | These patients underwent prostatectomy after serum was collected. |
Sample Preparation:
Sampleprep ID: | SP001133 |
Sampleprep Summary: | Proteins were precipitated from serum samples using either MeOH (for HILIC LC/MS and NMR) or Isopropanol (for RP LC/MS). Samples stored in -80 until analyzed |
Extract Storage: | -80C |
Combined analysis:
Analysis ID | AN001766 | AN001767 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | HILIC | HILIC |
Chromatography system | Thermo Dionex Ultimate 3000 | Thermo Dionex Ultimate 3000 |
Column | Waters Xbridge BEH HILIC (75 x 2.1mm,2.5um) | Waters Xbridge BEH HILIC (75 x 2.1mm,2.5um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive HF hybrid Orbitrap | Thermo Q Exactive HF hybrid Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | Relative abundance | Relative abundance |
Chromatography:
Chromatography ID: | CH001248 |
Instrument Name: | Thermo Dionex Ultimate 3000 |
Column Name: | Waters Xbridge BEH HILIC (75 x 2.1mm,2.5um) |
Column Temperature: | 50 |
Flow Gradient: | 0-7.0 min. 63% A; 7.0-7.2 min 5% A with an increased flow rate of 500 µL min-1; 7.2-9.9 min 5% A with a decreased flow rate of 300 µL min-1; and 9.9-10.0 min held at 5% A |
Flow Rate: | 300 µL min-1 |
Solvent A: | 5% acetonitrile/95% water; 10 mM ammonium formate; 0.05% ammonium hydroxide |
Solvent B: | 100% acetonitrile; 0.05% ammonium hydroxide |
Analytical Time: | 10 min |
Chromatography Type: | HILIC |
MS:
MS ID: | MS001633 |
Analysis ID: | AN001766 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
Ion Mode: | POSITIVE |
MS ID: | MS001634 |
Analysis ID: | AN001767 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
Ion Mode: | NEGATIVE |